Treatment Overview
Botox therapy for Neurogenic Overactive Bladder (N-OAB) is a minimally invasive procedure designed for patients with bladder dysfunction caused by neurological conditions such as spinal cord injury, multiple sclerosis, or spina bifida. Botulinum toxin (OnabotulinumtoxinA) is injected into the bladder wall to reduce involuntary detrusor contractions, improve bladder capacity, and prevent urinary incontinence. Korea is recognized internationally for its expertise in managing neurogenic bladder, combining advanced cystoscopic technology, precise dosing protocols, and multidisciplinary care.
Purpose & Benefits
The primary purpose of Botox therapy for N-OAB is to restore bladder control, prevent incontinence, and protect renal function. Key benefits include:
- Reduces urinary urgency, frequency, and urge incontinence associated with neurogenic bladder
- Improves bladder storage capacity and function
- Minimally invasive outpatient procedure with rapid recovery
- Alternative to long-term oral medications or invasive surgeries
- Repeatable every 6–12 months for sustained symptom management
- Reduces risk of urinary tract infections and upper urinary tract damage
Korean hospitals offer personalized treatment plans based on the patient’s neurological condition, bladder function, and prior treatment history.
Ideal Candidates
Ideal candidates include:
- Adults with neurogenic bladder resulting from spinal cord injury, multiple sclerosis, or spina bifida
- Patients experiencing persistent OAB symptoms unresponsive to medications
- Individuals at risk of upper urinary tract damage due to bladder dysfunction
- Medically suitable patients without contraindications to Botox
Pre-procedure evaluation ensures that there are no active infections, bladder obstruction, or hypersensitivity to Botox.
Possible Risks & Complications
Botox therapy for neurogenic OAB is generally safe, but potential risks include:
- Temporary urinary retention requiring intermittent catheterization
- Mild hematuria (blood in urine)
- Urinary tract infections
- Temporary bladder spasms or pelvic discomfort
- Rare allergic reactions
Korean hospitals minimize risks through precise cystoscopic injections, dosing based on bladder capacity, and careful monitoring.
Techniques & Technology Used
Advanced techniques used in Korea include:
- Cystoscopic-guided injections for accurate placement of Botox in the bladder wall
- Customized dosing based on bladder capacity and severity of neurogenic symptoms
- Integration with urodynamic studies before and after treatment to assess bladder function
- Post-procedure monitoring to prevent complications and ensure safety
- Repeat injection planning to maintain long-term bladder control
These techniques ensure effective symptom management while minimizing risks.
Treatment Process in Korea
The treatment process includes:
- Comprehensive evaluation including urinalysis, bladder diary, and urodynamic studies
- Botox injection procedure under local or general anesthesia, typically on an outpatient basis
- Observation period for immediate side effects
- Follow-up visits to monitor bladder function and manage complications
- Repeat injections every 6–12 months if needed for ongoing symptom control
- Patient education on intermittent catheterization, fluid intake, and bladder care
Multilingual coordinators assist international patients with scheduling, logistics, and aftercare.
Recovery & After-Care
Recovery is typically quick due to the minimally invasive nature of the procedure. Aftercare includes:
- Monitoring for urinary retention and urinary tract infections
- Maintaining proper hydration
- Avoiding strenuous activity for 24 hours post-procedure
- Attending follow-up appointments to evaluate bladder function
- Learning intermittent self-catheterization if temporary urinary retention occurs
Telemedicine support is available for international patients.
Results & Longevity
Botox therapy for neurogenic OAB in Korea provides significant symptom relief, typically lasting 6–12 months. Repeat injections help maintain long-term bladder control, reduce incontinence, and protect renal function. Most patients experience minimal side effects with improved quality of life.
Why Korea Is a Top Destination
Korea is preferred for Botox therapy for neurogenic OAB due to:
- Expertise in managing neurogenic bladder and OAB
- Advanced cystoscopic technology for precise injections
- Integration with urodynamic testing for personalized treatment
- Efficient outpatient scheduling with minimal waiting times
- Multilingual support and international patient coordination
- Cost-effective treatment without compromising quality
Patients benefit from expert care, precise therapy, and structured long-term follow-up.
Cost Range
The cost of Botox therapy for neurogenic OAB in Korea typically ranges from USD 1,800 to USD 4,000 per session, depending on:
- Hospital type and facility fees
- Number of Botox units and injection sites
- Follow-up consultations and monitoring
Hospitals provide transparent packages for international patients covering all essential treatment steps.
Popular Clinics in Korea
- Asan Medical Center – Urology & Neuro-Urology Clinic
- Seoul National University Hospital – Neurogenic Bladder & OAB Program
- Samsung Medical Center – Neurogenic OAB Botox Therapy Unit
- Severance Hospital (Yonsei University) – Urology & Bladder Control Clinic
- Korea University Anam Hospital – Outpatient Neurogenic OAB Clinic
- Seoul St. Mary’s Hospital – Neurogenic Bladder Management & Botox Therapy Unit
